← Back to Patent Explorer
US3935259A Expired / Lapsed US ⏱️ 0.0 years remaining

New amines and processes for their manufacture

Assignee: Novartis Corp
•
Filing: 1973-05-17
•
Granted: 1976-01-27
•
Expires: 1993-05-17
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Compounds selected from the group consisting of amines of the formula I ##EQU1## in which R 1 and R 2 stand for a member selected from lower alkyl, lower alkenyl, cycloalkyl having 4 to 7 ring members, phenyl-lower alkyl, phenyl-lower alkyl substituted in the phenyl residue by a member selected from lower alkyl, lower alkoxy, halogen and trifluoromethyl, lower alkylene, oxalower alkylene, aza-lower alkylene and thia-lower alkylene, and one of R 1 and R 2 stands for hydrogen and the other has the above meanings, Ph stands for a member selected from meta- and para-phenylene and meta- and para-phenylene substituted by a member selected from lower alkyl, lower alkenyl, lower alkinyl, mercapto-lower alkyl, hydroxy-lower alkyl, phenyl, cyano, hydrogen, halogen, lower alkoxy, lower alkenyloxy, lower alkinyloxy, mono-, di and trihalogeno-lower alkyl, cycloalkyl having 5 to 7 ring members and phenoxy, and R 3 stands for a member selected from lower alkyl and cycloalkyl having 5 to 7 ring members, and their condensation product with aldehydes and ketones, and their salts are useful as agents for the inhibition of the cardiac β-receptors.

Inventors

  • 👤 Max Wilhelm

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-29 23:40
CPC Classifications
C; C07; C07C; C07C275/00; C07C275/28; C07C275/32; C07C275/34

Claims Analysis

Total Claims: 9
Claim 1
Independent Claim 68 words
A compound of formula ##EQU17## wherein R 1 , R 2 and R 3 each represent lower alkyl having up to 7 carbon atoms or R 1 is hydrogen, Ph represents a meta- or paraphenylene bivalent radical, unsubstituted or substituted by a member of the group consisting of allyl, allyloxy, lower alkoxy of up to 4 carbon atoms, chlorine or bromine, and salts thereof with pharmaceutically acceptable acids.
Claim 2
Dependent Claim 68 words
A compound of formula ##EQU17## wherein R 1 , R 2 and R 3 each represent lower alkyl having up to 7 carbon atoms or R 1 is hydrogen, Ph represents a meta- or paraphenylene bivalent radical, unsubstituted or substituted by a member of the group consisting of allyl, allyloxy, lower alkoxy of up to 4 carbon atoms, chlorine or bromine, and salts thereof with pharmaceutically acceptable acids.
Claim 3
Dependent Claim 68 words
A compound as claimed in claim 1 having the formula ##SPC8## wherein R 1 , R 2 and R 3 each represent lower alkyl having up to 4 carbon atoms or one of R 1 and R 2 is hydrogen, R 4 represents a member selected from allyl, hydrogen, chlorine, bromine, lower alkoxy of up to 4 carbon atoms and allyloxy, and salts thereof with pharmaceutically acceptable acids.
Claim 4
Dependent Claim 19 words
A product as claimed in claim 2, said product being 1-[(p-N',N'-dimethylureido)-phenoxy]-2-hydroxy-3-isopropylamino-propane or a therapeutically usable acid addition salt thereof.
Claim 5
Dependent Claim 19 words
A product as claimed in claim 2, said product being 1-[(o-chloro-p-N',N'-dimethylureido)-phenoxy]-2-hydroxy-3-isopropylamino-propane or a therapeutically usable acid addition salt thereof.
Claim 6
Dependent Claim 19 words
A product as claimed in claim 1, said product being 1-[(m-N',N'-dimethylureido)-phenoxy]-2-hydroxy-3-isopropylamino-propane or a therapeutically usable acid addition salt thereof.
Claim 7
Dependent Claim 19 words
A product as claimed in claim 2, said product being 1-[(o-allyl-p-N',N'-dimethylureido)-phenoxy]-2-hydroxy-3-isopropylamino-propane or a therapeutically usable acid addition salt thereof.
Claim 8
Dependent Claim 19 words
A product as claimed in claim 2, said product being 1-[(o-methoxy-p-N',N'-dimethylureido)-phenoxy]-2-hydroxy-3-isopropylamino-propane or a therapeutically usable acid addition salt thereof.
Claim 9
Dependent Claim 19 words
A product as claimed in claim 2, said product being 1-[(p-N'-methylureido)-phenoxy]-2-hydroxy-3-isopropylaminopropane or a therapeutically usable acid addition salt thereof.

References Cited (Backward Citations)

FR1458635A Cited
FR1543690A Cited
US3644520A Cited
US3663607A Cited
US3689524A Cited
US3660486A Cited
NL7100178A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1979-01-26 1979-07-28 1980-01-27 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1983-01-26 1983-07-28 1984-01-27 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1987-01-26 1987-07-28 1988-01-27 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag